Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-008717
Filing Date
2020-05-14
Accepted
2020-05-14 15:20:35
Documents
80
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1593367
2 ex10-59.htm EX-10.59 59958
3 ex10-60.htm EX-10.60 52846
4 ex10-62.htm EX-10.62 384050
5 ex10-64.htm EX-10.64 109347
6 ex10-65.htm EX-10.65 16329
7 ex31-1.htm EX-31.1 15859
8 ex31-2.htm EX-31.2 15775
9 ex32-1.htm EX-32.1 7542
10 image_005.jpg GRAPHIC 2661
11 image_006.jpg GRAPHIC 4996
12 image_004.jpg GRAPHIC 46847
13 image_003.jpg GRAPHIC 2448
  Complete submission text file 0001493152-20-008717.txt   5730392

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE imun-20191231.xml EX-101.INS 661367
15 XBRL SCHEMA FILE imun-20191231.xsd EX-101.SCH 62845
16 XBRL CALCULATION FILE imun-20191231_cal.xml EX-101.CAL 61914
17 XBRL DEFINITION FILE imun-20191231_def.xml EX-101.DEF 208778
18 XBRL LABEL FILE imun-20191231_lab.xml EX-101.LAB 361980
19 XBRL PRESENTATION FILE imun-20191231_pre.xml EX-101.PRE 296653
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

EIN.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54933 | Film No.: 20877333
SIC: 2834 Pharmaceutical Preparations